-
ABT-199 (Venetoclax): Precision Bcl-2 Inhibition in Apoptosi
2026-05-20
ABT-199 (Venetoclax) delivers highly selective Bcl-2 inhibition, empowering apoptosis research in hematologic malignancies with minimal off-target toxicity. This guide translates the latest experimental advances and combinatorial strategies into actionable workflows, ensuring robust and reproducible results.
-
Filipin III: Precision Cholesterol Detection in Membrane Res
2026-05-20
Filipin III, a polyene macrolide antibiotic from APExBIO, is the gold standard for visualizing and quantifying cholesterol-rich microdomains in cell membranes. This article delivers actionable workflows, advanced troubleshooting, and insights from cutting-edge research, empowering you to drive impactful lipid biology experiments.
-
Berbamine Hydrochloride: Mechanistic Insights for NF-κB Inhi
2026-05-19
Explore how Berbamine hydrochloride acts as a potent NF-κB activity inhibitor, delving into advanced mechanistic and methodological insights for cancer research. This article uniquely integrates the latest findings on ferroptosis resistance and practical assay design.
-
Transmission of Carbapenemase Genes in CREC: Insights from G
2026-05-19
Chen et al. (2025) provide a high-resolution molecular and epidemiological analysis of carbapenemase-encoding genes in carbapenem-resistant Enterobacter cloacae (CREC) from eight teaching hospitals in Guangdong, China. Their findings reveal predominant plasmid-mediated blaNDM-1 carriage, frequent multidrug resistance, and substantial gene transfer capacity, with important implications for resistance surveillance and laboratory modeling.
-
Applied Workflows for EZ Cap™ Human PTEN mRNA (ψUTP) in Canc
2026-05-18
EZ Cap™ Human PTEN mRNA (ψUTP) empowers researchers to restore PTEN function and robustly inhibit the PI3K/Akt pathway, leveraging advanced mRNA stability and immune evasion. Discover hands-on workflow enhancements, troubleshooting strategies, and actionable integration of nanoparticle delivery to overcome therapeutic resistance in cancer models.
-
Ziprasidone HCl: Protocols for GOT1 Inhibition & Oncology Re
2026-05-18
Ziprasidone Hydrochloride (Ziprasidone HCl) bridges neuroscience and oncology, combining potent serotonin/dopamine receptor antagonism with validated GOT1 inhibition for advanced cancer and neurotransmitter pathway studies. This guide delivers workflow-tested parameters, troubleshooting insight, and translational advantages for researchers seeking reproducibility and innovation.
-
EZ Cap™ Human PTEN mRNA (ψUTP): Innovations in mRNA Stabilit
2026-05-17
Explore how EZ Cap™ Human PTEN mRNA (ψUTP) sets a new standard in in vitro transcribed mRNA technology, enabling advanced mRNA stability enhancement and effective PI3K/Akt pathway inhibition for cancer research. This article uncovers novel insights drawn from recent nanoparticle-mediated mRNA delivery breakthroughs.
-
Low-Affinity Blockade of N-Type Ca Channels by v-Agatoxin-IV
2026-05-16
This study redefines the pharmacological selectivity of the spider toxin v-Agatoxin-IVA, demonstrating its low-affinity blockade of neuronal N-type calcium channels in addition to its established high-affinity inhibition of P-type channels. These findings refine the use of v-Agatoxin-IVA as a tool for distinguishing calcium channel subtypes in neurophysiological research and highlight the importance of concentration-dependent specificity.
-
Adefovir (GS-0393): Optimizing HBV Antiviral Workflows in Re
2026-05-15
Adefovir (GS-0393) from APExBIO enables precise, reproducible hepatitis B virus research by targeting HBV DNA polymerase with high selectivity and water solubility. Explore protocol enhancements, advanced applications, and troubleshooting strategies that set this HBV antiviral agent apart for both virology and transporter studies.
-
Nanoparticle-mRNA Delivery Overcomes Trastuzumab Resistance
2026-05-15
This study demonstrates a nanoparticle-based strategy for systemic delivery of PTEN mRNA to restore trastuzumab sensitivity in HER2-positive breast cancer models. By reinstating tumor suppressor function and inhibiting the PI3K/Akt pathway, this approach addresses a critical mechanism of therapy resistance with translational potential.
-
Octanoic Acid in IBD: PPARγ/STAT Pathway and Macrophage Bala
2026-05-14
This study demonstrates that octanoic acid-rich enteral nutrition alleviates inflammatory bowel disease by shifting intestinal macrophage polarization through the PPARγ/STAT-1/STAT-6 pathway. The findings illuminate nutritional immune modulation and suggest new directions for targeted IBD therapies.
-
Viral Targeting of RIPK3: Mechanisms Regulating Necroptosis
2026-05-14
Liu et al. identified a viral protein (vIRD) in orthopoxviruses that binds to host SCF ubiquitin ligase machinery and the necroptosis kinase RIPK3, triggering its ubiquitin–proteasome-mediated degradation. This study reveals a novel viral strategy for suppressing necroptosis and modulating inflammation, with broad implications for understanding host-pathogen interactions.
-
Synergistic Colistin-Gamithromycin Activity in Neutropenic L
2026-05-13
This study evaluates the combined antimicrobial efficacy of colistin and gamithromycin against Pasteurella multocida in a neutropenic murine lung infection model. The findings reveal a significant synergistic effect, particularly in strains with high colistin MICs, providing actionable insights for optimizing treatment regimens and mitigating resistance development.
-
BIIE 0246: Precision Use of a Neuropeptide Y Y2 Receptor Ant
2026-05-13
BIIE 0246 empowers researchers to dissect the neuropeptide Y Y2 receptor's role in neural, metabolic, and cardiovascular signaling. This guide delivers workflow enhancements, troubleshooting strategies, and protocol parameters to maximize the reproducibility and impact of Y2R antagonist studies.
-
Açaí Extracts: Cytotoxicity and Enzyme Modulation in Hepatoc
2026-05-12
This study systematically evaluates the cytotoxic and enzyme induction effects of various açaí (Euterpe oleracea) extracts in human hepatocytes. The findings clarify safety concerns and demonstrate a low potential for drug-metabolizing enzyme and transporter induction, informing future research on botanical supplement safety and drug interaction risk.